| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
6e-07 |
| mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
| mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.3 |
6e-05 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0002 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0003 |